These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 20335288

  • 1. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T, CAPNETZ Study Group.
    Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
    [Abstract] [Full Text] [Related]

  • 2. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.
    Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T, CAPNETZ Study Group.
    Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883
    [Abstract] [Full Text] [Related]

  • 3. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.
    Krüger S, Ewig S, Giersdorf S, Hartmann O, Frechen D, Rohde G, Suttorp N, Welte T, CAPNETZ study group.
    Respir Med; 2014 Nov; 108(11):1696-705. PubMed ID: 25306251
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T, German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.
    Am J Respir Crit Care Med; 2010 Dec 01; 182(11):1426-34. PubMed ID: 20639437
    [Abstract] [Full Text] [Related]

  • 5. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
    Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Müller B, Schuetz P.
    Int J Cardiol; 2012 Apr 05; 156(1):16-23. PubMed ID: 21093937
    [Abstract] [Full Text] [Related]

  • 6. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F.
    Clin Chem; 2007 Dec 05; 53(12):2193-201. PubMed ID: 17951293
    [Abstract] [Full Text] [Related]

  • 7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 8. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, Tanglay Y, Heinisch C, Reiter M, Drexler B, Arenja N, Twerenbold R, Stolz D, Tamm M, Müller B, Müller C.
    Chest; 2012 Apr 13; 141(4):974-982. PubMed ID: 22135381
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.
    J Card Fail; 2007 Feb 13; 13(1):42-9. PubMed ID: 17339002
    [Abstract] [Full Text] [Related]

  • 10. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.
    Crit Care; 2006 Feb 13; 10(3):R96. PubMed ID: 16805922
    [Abstract] [Full Text] [Related]

  • 11. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T, CAPNETZ Study Group.
    J Antimicrob Chemother; 2009 Jul 13; 64(1):159-62. PubMed ID: 19403654
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.
    J Intern Med; 2006 Dec 13; 260(6):568-76. PubMed ID: 17116008
    [Abstract] [Full Text] [Related]

  • 13. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 14. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M.
    J Am Coll Cardiol; 2010 Sep 21; 56(13):1045-53. PubMed ID: 20846604
    [Abstract] [Full Text] [Related]

  • 15. Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort.
    Fedorowski A, Burri P, Struck J, Juul-Möller S, Melander O.
    J Intern Med; 2013 Apr 21; 273(4):359-67. PubMed ID: 23510366
    [Abstract] [Full Text] [Related]

  • 16. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study.
    Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B.
    Crit Care; 2005 Feb 21; 9(1):R37-45. PubMed ID: 15693965
    [Abstract] [Full Text] [Related]

  • 17. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 18. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 19. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE, Stavem K, Omland T, Hall C, Smith-Erichssen N.
    Acta Anaesthesiol Scand; 2008 Oct 12; 52(9):1265-72. PubMed ID: 18823467
    [Abstract] [Full Text] [Related]

  • 20. CRB-65 predicts death from community-acquired pneumonia.
    Bauer TT, Ewig S, Marre R, Suttorp N, Welte T, CAPNETZ Study Group.
    J Intern Med; 2006 Jul 12; 260(1):93-101. PubMed ID: 16789984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.